Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Drug-induced lupus: Traditional and new concepts.

Vaglio A, Grayson PC, Fenaroli P, Gianfreda D, Boccaletti V, Ghiggeri GM, Moroni G.

Autoimmun Rev. 2018 Sep;17(9):912-918. doi: 10.1016/j.autrev.2018.03.016. Epub 2018 Jul 10. Review.

PMID:
30005854
2.

Characterisation of the nasal microbiota in granulomatosis with polyangiitis.

Rhee RL, Sreih AG, Najem CE, Grayson PC, Zhao C, Bittinger K, Collman RG, Merkel PA.

Ann Rheum Dis. 2018 Oct;77(10):1448-1453. doi: 10.1136/annrheumdis-2018-213645. Epub 2018 Jul 11.

PMID:
29997110
3.

Deficiency of Adenosine Deaminase 2 in Adult Siblings: Many Years of a Misdiagnosed Disease With Severe Consequences.

Springer JM, Gierer SA, Jiang H, Kleiner D, Deuitch N, Ombrello AK, Grayson PC, Aksentijevich I.

Front Immunol. 2018 Jun 14;9:1361. doi: 10.3389/fimmu.2018.01361. eCollection 2018.

4.

Metabolic pathways and immunometabolism in rare kidney diseases.

Grayson PC, Eddy S, Taroni JN, Lightfoot YL, Mariani L, Parikh H, Lindenmeyer MT, Ju W, Greene CS, Godfrey B, Cohen CD, Krischer J, Kretzler M, Merkel PA; Vasculitis Clinical Research Consortium, the European Renal cDNA Bank cohort, and the Nephrotic Syndrome Study Network.

Ann Rheum Dis. 2018 Aug;77(8):1226-1233. doi: 10.1136/annrheumdis-2017-212935. Epub 2018 May 3.

5.

Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus.

Carlucci PM, Purmalek MM, Dey AK, Temesgen-Oyelakin Y, Sakhardande S, Joshi AA, Lerman JB, Fike A, Davis M, Chung JH, Playford MP, Naqi M, Mistry P, Gutierrez-Cruz G, Dell'Orso S, Naz F, Salahuddin T, Natarajan B, Manna Z, Tsai WL, Gupta S, Grayson P, Teague H, Chen MY, Sun HW, Hasni S, Mehta NN, Kaplan MJ.

JCI Insight. 2018 Apr 19;3(8). pii: 99276. doi: 10.1172/jci.insight.99276. [Epub ahead of print]

6.

Comparison of magnetic resonance angiography and 18F-fluorodeoxyglucose positron emission tomography in large-vessel vasculitis.

Quinn KA, Ahlman MA, Malayeri AA, Marko J, Civelek AC, Rosenblum JS, Bagheri AA, Merkel PA, Novakovich E, Grayson PC.

Ann Rheum Dis. 2018 Aug;77(8):1165-1171. doi: 10.1136/annrheumdis-2018-213102. Epub 2018 Apr 17.

PMID:
29666047
7.

Use of "Provisional" Designation for Response Criteria.

Johnson SR, Grayson PC.

Arthritis Care Res (Hoboken). 2018 Jun;70(6):811-812. doi: 10.1002/acr.23555. Epub 2018 Apr 25. No abstract available.

PMID:
29575810
8.

Patient Perception of Disease-Related Symptoms and Complications in Relapsing Polychondritis.

Ferrada MA, Grayson PC, Banerjee S, A Sikora K, A Colbert R, Sinaii N, Katz JD.

Arthritis Care Res (Hoboken). 2018 Aug;70(8):1124-1131. doi: 10.1002/acr.23492. Epub 2018 Jul 4.

PMID:
29245173
9.

18 F-Fluorodeoxyglucose-Positron Emission Tomography As an Imaging Biomarker in a Prospective, Longitudinal Cohort of Patients With Large Vessel Vasculitis.

Grayson PC, Alehashemi S, Bagheri AA, Civelek AC, Cupps TR, Kaplan MJ, Malayeri AA, Merkel PA, Novakovich E, Bluemke DA, Ahlman MA.

Arthritis Rheumatol. 2018 Mar;70(3):439-449. doi: 10.1002/art.40379. Epub 2018 Feb 6.

PMID:
29145713
10.

Brief Report: Drugs Implicated in Systemic Autoimmunity Modulate Neutrophil Extracellular Trap Formation.

Irizarry-Caro JA, Carmona-Rivera C, Schwartz DM, Khaznadar SS, Kaplan MJ, Grayson PC.

Arthritis Rheumatol. 2018 Mar;70(3):468-474. doi: 10.1002/art.40372. Epub 2018 Jan 23.

PMID:
29121457
11.

Comparative Genomics as a Foundation for Evo-Devo Studies in Birds.

Grayson P, Sin SYW, Sackton TB, Edwards SV.

Methods Mol Biol. 2017;1650:11-46. doi: 10.1007/978-1-4939-7216-6_2.

PMID:
28809012
12.

Abnormal molecular response to Takayasu arteritis causing extensive large-vessel calcification.

Garland BT, Boehm M, Grayson PC, Hilaire CS, Brofferio A, Starnes BW.

J Vasc Surg Cases Innov Tech. 2016 Dec;2(4):190-192. doi: 10.1016/j.jvscit.2016.05.004.

13.

Are the 1990 American College of Rheumatology vasculitis classification criteria still valid?

Seeliger B, Sznajd J, Robson JC, Judge A, Craven A, Grayson PC, Suppiah RS, Watts RA, Merkel PA, Luqmani RA.

Rheumatology (Oxford). 2017 Jul 1;56(7):1154-1161. doi: 10.1093/rheumatology/kex075.

PMID:
28379475
14.

Treatment of mucocutaneous manifestations in Beh├žet's disease with anakinra: a pilot open-label study.

Grayson PC, Yazici Y, Merideth M, Sen HN, Davis M, Novakovich E, Joyal E, Goldbach-Mansky R, Sibley CH.

Arthritis Res Ther. 2017 Mar 24;19(1):69. doi: 10.1186/s13075-017-1222-3.

15.

A role for muscarinic receptors in neutrophil extracellular trap formation and levamisole-induced autoimmunity.

Carmona-Rivera C, Purmalek MM, Moore E, Waldman M, Walter PJ, Garraffo HM, Phillips KA, Preston KL, Graf J, Kaplan MJ, Grayson PC.

JCI Insight. 2017 Feb 9;2(3):e89780. doi: 10.1172/jci.insight.89780.

16.

Vasculitis Around the World: Epidemiologic Insights into Causality and a Need for Global Partnerships.

Banerjee S, Grayson PC.

J Rheumatol. 2017 Feb;44(2):136-139. doi: 10.3899/jrheum.161468. No abstract available.

PMID:
28148752
17.

Response to eLetter: 'Infections in giant cell arteritis and therapeutic implications' by Moiseev et al.

Rhee RL, Grayson PC, Merkel PA, Tomasson G.

Ann Rheum Dis. 2017 Sep;76(9):e30. doi: 10.1136/annrheumdis-2016-210976. Epub 2017 Jan 17. No abstract available.

PMID:
28096072
18.

Infections and the risk of incident giant cell arteritis: a population-based, case-control study.

Rhee RL, Grayson PC, Merkel PA, Tomasson G.

Ann Rheum Dis. 2017 Jun;76(6):1031-1035. doi: 10.1136/annrheumdis-2016-210152. Epub 2016 Nov 28.

PMID:
27895041
19.

The Controversial Second Impact Syndrome: A Review of the Literature.

McLendon LA, Kralik SF, Grayson PA, Golomb MR.

Pediatr Neurol. 2016 Sep;62:9-17. doi: 10.1016/j.pediatrneurol.2016.03.009. Epub 2016 Apr 13. Review.

PMID:
27421756
20.

Review: Neutrophils as Invigorated Targets in Rheumatic Diseases.

Grayson PC, Schauer C, Herrmann M, Kaplan MJ.

Arthritis Rheumatol. 2016 Sep;68(9):2071-82. doi: 10.1002/art.39745. Epub 2016 Jul 29. Review. No abstract available.

21.

Izumo1 and Juno: the evolutionary origins and coevolution of essential sperm-egg binding partners.

Grayson P.

R Soc Open Sci. 2015 Dec 16;2(12):150296. doi: 10.1098/rsos.150296. eCollection 2015 Dec.

22.

Diagnosis of Giant Cell Arteritis in an Asymptomatic Patient.

Newman KA, Ahlman MA, Hughes M, Malayeri AA, Pratt D, Grayson PC.

Arthritis Rheumatol. 2016 May;68(5):1135. doi: 10.1002/art.39517. No abstract available.

23.

A small n sequential multiple assignment randomized trial design for use in rare disease research.

Tamura RN, Krischer JP, Pagnoux C, Micheletti R, Grayson PC, Chen YF, Merkel PA.

Contemp Clin Trials. 2016 Jan;46:48-51. doi: 10.1016/j.cct.2015.11.010. Epub 2015 Nov 14.

24.

At the Bench: Neutrophil extracellular traps (NETs) highlight novel aspects of innate immune system involvement in autoimmune diseases.

Grayson PC, Kaplan MJ.

J Leukoc Biol. 2016 Feb;99(2):253-64. doi: 10.1189/jlb.5BT0615-247R. Epub 2015 Oct 2. Review.

25.

What matters for patients with vasculitis?

Novakovich E, Grayson PC.

Presse Med. 2015 Jun;44(6 Pt 2):e267-72. doi: 10.1016/j.lpm.2015.01.016. Epub 2015 May 16. Review.

PMID:
25986940
26.

Defining the nasal transcriptome in granulomatosis with polyangiitis (Wegener's).

Grayson PC, Steiling K, Platt M, Berman JS, Zhang X, Xiao J, Alekseyev YO, Liu G, Monach PA, Kaplan MJ, Spira A, Merkel PA.

Arthritis Rheumatol. 2015 May;67(8):2233-9. doi: 10.1002/art.39185.

27.

Neutrophil-Related Gene Expression and Low-Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Grayson PC, Carmona-Rivera C, Xu L, Lim N, Gao Z, Asare AL, Specks U, Stone JH, Seo P, Spiera RF, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Tchao NK, Ytterberg SR, Phippard DJ, Merkel PA, Kaplan MJ, Monach PA; Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group.

Arthritis Rheumatol. 2015 Jul;67(7):1922-32. doi: 10.1002/art.39153.

28.

Lumpers and splitters: ongoing issues in the classification of large vessel vasculitis.

Grayson PC.

J Rheumatol. 2015 Feb;42(2):149-51. doi: 10.3899/jrheum.141376. No abstract available.

PMID:
25641963
29.

Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis.

Grayson PC, Monach PA, Pagnoux C, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, Koening CL, Langford CA, Maksimowicz-McKinnon K, Seo P, Specks U, Ytterberg SR, Merkel PA; Vasculitis Clinical Research Consortium.

Rheumatology (Oxford). 2015 Aug;54(8):1351-9. doi: 10.1093/rheumatology/keu427. Epub 2014 Nov 17.

30.

Eosinophils in vasculitis: characteristics and roles in pathogenesis.

Khoury P, Grayson PC, Klion AD.

Nat Rev Rheumatol. 2014 Aug;10(8):474-83. doi: 10.1038/nrrheum.2014.98. Epub 2014 Jul 8. Review.

31.

Causal attributions about disease onset and relapse in patients with systemic vasculitis.

Grayson PC, Amudala NA, McAlear CA, Leduc RL, Shereff D, Richesson R, Fraenkel L, Merkel PA.

J Rheumatol. 2014 May;41(5):923-30. doi: 10.3899/jrheum.131096. Epub 2014 Mar 15.

32.

The informational needs of patients with ANCA-associated vasculitis-development of an informational needs questionnaire.

Mooney J, Spalding N, Poland F, Grayson P, Leduc R, McAlear CA, Richesson RL, Shereff D, Merkel PA, Watts RA.

Rheumatology (Oxford). 2014 Aug;53(8):1414-21. doi: 10.1093/rheumatology/keu026. Epub 2014 Mar 12.

33.
34.

Ultrasound assessment of subcutaneous compressibility: a potential adjunctive diagnostic tool in eosinophilic fasciitis.

Kissin EY, Garg A, Grayson PC, Dubreuil M, Vradii D, York M, Simms RW.

J Clin Rheumatol. 2013 Oct;19(7):382-5. doi: 10.1097/RHU.0000000000000020.

PMID:
24048117
35.

ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS).

Craven A, Robson J, Ponte C, Grayson PC, Suppiah R, Judge A, Watts R, Merkel PA, Luqmani RA.

Clin Exp Nephrol. 2013 Oct;17(5):619-621. doi: 10.1007/s10157-013-0854-0. Epub 2013 Aug 31.

PMID:
23996327
36.

Musculoskeletal ultrasound objective structured clinical examination: an assessment of the test.

Kissin EY, Grayson PC, Cannella AC, Demarco PJ, Evangelisto A, Goyal J, Al Haj R, Higgs J, Malone DG, Nishio MJ, Tabechian D, Kaeley GS.

Arthritis Care Res (Hoboken). 2014 Jan;66(1):2-6. doi: 10.1002/acr.22105.

37.

New features of disease after diagnosis in 6 forms of systemic vasculitis.

Grayson PC, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, Koening CL, Langford CA, Maksimowicz-McKinnon K, Monach PA, Seo P, Specks U, Ytterberg SR, Merkel PA; Vasculitis Clinical Research Consortium.

J Rheumatol. 2013 Nov;40(11):1905-12. doi: 10.3899/jrheum.121473. Epub 2013 Aug 1.

38.

Illness perceptions and fatigue in systemic vasculitis.

Grayson PC, Amudala NA, Mcalear CA, Leduc RL, Shereff D, Richesson R, Fraenkel L, Merkel PA.

Arthritis Care Res (Hoboken). 2013 Nov;65(11):1835-43.

39.

Positive Selection and the Evolution of izumo Genes in Mammals.

Grayson P, Civetta A.

Int J Evol Biol. 2012;2012:958164. doi: 10.1155/2012/958164. Epub 2012 Aug 21.

40.

Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis.

Grayson PC, Maksimowicz-McKinnon K, Clark TM, Tomasson G, Cuthbertson D, Carette S, Khalidi NA, Langford CA, Monach PA, Seo P, Warrington KJ, Ytterberg SR, Hoffman GS, Merkel PA; Vasculitis Clinical Research Consortium.

Ann Rheum Dis. 2012 Aug;71(8):1329-34. doi: 10.1136/annrheumdis-2011-200795. Epub 2012 Feb 10.

41.

Relation of hand enthesophytes with knee enthesopathy: is osteoarthritis related to a systemic enthesopathy?

Gibson N, Guermazi A, Clancy M, Niu J, Grayson P, Aliabadi P, Roemer F, Felson DT.

J Rheumatol. 2012 Feb;39(2):359-64. doi: 10.3899/jrheum.110718. Epub 2011 Dec 15.

42.

Association of vascular physical examination findings and arteriographic lesions in large vessel vasculitis.

Grayson PC, Tomasson G, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, Langford CA, McAlear CA, Monach PA, Seo P, Warrington KJ, Ytterberg SR, Merkel PA; Vasculitis Clinical Research Consortium.

J Rheumatol. 2012 Feb;39(2):303-9. doi: 10.3899/jrheum.110652. Epub 2011 Dec 15.

43.

Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis--a meta-analysis.

Tomasson G, Grayson PC, Mahr AD, Lavalley M, Merkel PA.

Rheumatology (Oxford). 2012 Jan;51(1):100-9. doi: 10.1093/rheumatology/ker280. Epub 2011 Oct 29.

44.

Antineutrophil cytoplasmic antibodies, autoimmune neutropenia, and vasculitis.

Grayson PC, Sloan JM, Niles JL, Monach PA, Merkel PA.

Semin Arthritis Rheum. 2011 Dec;41(3):424-33. doi: 10.1016/j.semarthrit.2011.02.003. Epub 2011 Apr 19.

45.

Nomenclature and classification of vasculitis - update on the ACR/EULAR diagnosis and classification of vasculitis study (DCVAS).

Luqmani RA, Suppiah R, Grayson PC, Merkel PA, Watts R.

Clin Exp Immunol. 2011 May;164 Suppl 1:11-3. doi: 10.1111/j.1365-2249.2011.04358.x. Review.

46.

Hyperuricemia and incident hypertension: a systematic review and meta-analysis.

Grayson PC, Kim SY, LaValley M, Choi HK.

Arthritis Care Res (Hoboken). 2011 Jan;63(1):102-10. doi: 10.1002/acr.20344. Review.

47.

A pilot study to assess the efficacy of biofeedback-assisted relaxation training as an adjunct treatment for pediatric functional dyspepsia associated with duodenal eosinophilia.

Schurman JV, Wu YP, Grayson P, Friesen CA.

J Pediatr Psychol. 2010 Sep;35(8):837-47. doi: 10.1093/jpepsy/jsq010. Epub 2010 Feb 25.

PMID:
20185416
48.

Family needs assessment in cerebral palsy clinic.

Buran CF, Sawin K, Grayson P, Criss S.

J Spec Pediatr Nurs. 2009 Apr;14(2):86-93. doi: 10.1111/j.1744-6155.2008.00176.x.

PMID:
19356202
49.

Real-time observations of single bacteriophage lambda DNA ejections in vitro.

Grayson P, Han L, Winther T, Phillips R.

Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14652-7. Epub 2007 Sep 5.

50.

Is phage DNA 'injected' into cells--biologists and physicists can agree.

Grayson P, Molineux IJ.

Curr Opin Microbiol. 2007 Aug;10(4):401-9. Epub 2007 Aug 21. Review.

Supplemental Content

Loading ...
Support Center